Category: Products & Tech

Metformin Recalls: What You Need to Know

Diabetes and Cancer: Can Metformin Treat Both?

The association between diabetes and cancer was first noted over 100 years ago, but physicians have become increasingly aware of this association only in the last few years as recent studies have demonstrated that having diabetes increases the risk of almost all types of cancer. The risk of pancreatic, liver, and endometrial cancer is approximately twice that of the non-diabetic population. Some studies have reported a similar increase in the risk of bladder cancer and in cancers of the oral cavity.
0 Shares
gsk-logo

Children with Type 2 Diabetes do Better with Avandia

The results of a randomized clinical trial funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in children with type 2 diabetes show that children and adolescents treated with a combination of metformin and Avandia (rosiglitazone) had better glycemic control than children....
0 Shares
takeda_logo

FDA Requests More Data on Takeda’s Alogliptin

The FDA has issued a complete response letter to Japanese drug-maker Takeda Pharmaceutical regarding New Drug Applications (NDAs) for alogliptin and fixed-dose combination (FDC) alogliptin and pioglitazone...
0 Shares
Novo Nordisk Logo

Ultra Long Acting Insulin Degludec Reduces Nocturnal Hypoglycemia, New Studies Show

Two new phase 3 studies published in The Lancet show that ultra long acting insulin, Degludec, an investigational compound from Novo Nordisk, significantly reduces the rates of nocturnal hypoglycemia by 25%, compared to insulin glargine. The two studies included in total 1,635 participants and investigated insulin degludec compared to insulin...
0 Shares
biodel_logo

Positive Results for Biodel’s Ultra Rapid Acting Insulin

Biodel Inc. announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and BIOD-125 -- two proprietary ultra rapid acting formulations of recombinant human insulin (RHI). The objective of the trial was to identify...
0 Shares